Patents by Inventor Garry Steil

Garry Steil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070173761
    Abstract: An infusion system, which may be a closed loop infusion system or “semi-closed-loop” system, uses state variable feedback to controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The “semi-closed-loop” system further includes prompts that are displayed or sounded or otherwise provide indications to the user prior to insulin delivery. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. The system may use three state variables, subcutaneous insulin concentration, plasma insulin concentration, and insulin effect, and corresponding gains, to calculate an addition amount of liquid to be infused as a bolus and to be removed from the basal delivery of the liquid.
    Type: Application
    Filed: December 22, 2006
    Publication date: July 26, 2007
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Sami Kanderian, Garry Steil
  • Publication number: 20060272652
    Abstract: A system to assist an individual in developing a therapy in diabetes treatment of a patient includes a user interface control module, a simulation engine, a charting and display module. The user interface control module receives an input related to the patient and captures a current time of the simulation. The simulation engine receives the input, generates a plurality of blood glucose readings for the patient up to the current time of the simulation based on the input, and to transfers the plurality of blood glucose readings. The charting and display module receives the plurality of blood glucose readings and display the plurality of blood glucose readings. The simulation engine receives patient parameters from a patient parameter library based on a selected patient model.
    Type: Application
    Filed: June 3, 2005
    Publication date: December 7, 2006
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: David Stocker, Sami Kanderian, Gabriel Cortina, Tamir Nitzan, Jon Plummer, Garry Steil, John Mastrototaro
  • Publication number: 20060224109
    Abstract: A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin.
    Type: Application
    Filed: May 3, 2006
    Publication date: October 5, 2006
    Inventors: Garry Steil, Kerstin Rebrin
  • Publication number: 20060173406
    Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.
    Type: Application
    Filed: December 30, 2005
    Publication date: August 3, 2006
    Inventors: Andrew Hayes, John Mastrototaro, Sheldon Moberg, John Mueller, H. Clark, Mike Charles Tolle, Gary Williams, Bihong Wu, Garry Steil
  • Publication number: 20050113653
    Abstract: Apparatuses and methods for medical monitoring physiological characteristics values such as blood glucose levels for the treatment of diabetes, are presented. The apparatuses and methods provide dynamic glucose monitoring functions that perform predictive analysis to anticipate harmful conditions, such as glucose crash and hyperglycemic incidents for a patient. The dynamic functions can also be used to maximize athletic performance and warn of inadequate nocturnal basal rate. Other aspects include advanced alarm and reminder functions, as well as advanced data presentation tools to further facilitate convenient and efficient management of various physiological conditions.
    Type: Application
    Filed: November 30, 2004
    Publication date: May 26, 2005
    Inventors: James Fox, Garry Steil, Kerstin Rebrin, Mark Estes, Frank Saidara
  • Publication number: 20050096511
    Abstract: Apparatuses and methods for medical monitoring physiological characteristics values such as blood glucose levels for the treatment of diabetes, are presented. The apparatuses and methods provide dynamic glucose monitoring functions that perform predictive analysis to anticipate harmful conditions, such as glucose crash and hyperglycemic incidents for a patient. The dynamic functions can also be used to maximize athletic performance and warn of inadequate nocturnal basal rate. Other aspects include advanced alarm and reminder functions, as well as advanced data presentation tools to further facilitate convenient and efficient management of various physiological conditions.
    Type: Application
    Filed: November 30, 2004
    Publication date: May 5, 2005
    Inventors: James Fox, Garry Steil, Kerstin Rebrin, Mark Estes, Frank Saidara
  • Publication number: 20050096512
    Abstract: Apparatuses and methods for medical monitoring physiological characteristics values such as blood glucose levels for the treatment of diabetes, are presented. The apparatuses and methods provide dynamic glucose monitoring functions that perform predictive analysis to anticipate harmful conditions, such as glucose crash and hyperglycemic incidents for a patient. The dynamic functions can also be used to maximize athletic performance and warn of inadequate nocturnal basal rate. Other aspects include advanced alarm and reminder functions, as well as advanced data presentation tools to further facilitate convenient and efficient management of various physiological conditions.
    Type: Application
    Filed: November 30, 2004
    Publication date: May 5, 2005
    Inventors: James Fox, Garry Steil, Kerstin Rebrin, Mark Estes, Frank Saidara